Drug induced extrapyramidal effects--a review
Coleman, J.H.; Hayes, P.E.
Diseases of the Nervous System 36(10): 591-593
1975
ISSN/ISBN: 0012-3714 PMID: 1100334 Document Number: 92029
Document emailed within 1 workday
Related Documents
Elie, R.; Gagnon, M.A.; Gauthier, R.; Jéquier, J.C. 1975: Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia L'Union Medicale du Canada 104(6): 909-914Tune, L.E.; McHugh, P.R.; Coyle, J.T. 1981: Management of extrapyramidal side effects induced by neuroleptics Johns Hopkins Medical Journal 148(3): 149-153
Inada, T. 1996: Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients Nihon Shinkei Seishin Yakurigaku Zasshi 16(5): 181-185
Nakazono, Y.; Abe, H.; Murakami, H.; Koyabu, N.; Isaka, Y.; Nemoto, Y.; Murata, S.; Tsutsumi, Y.; Ohtani, H.; Sawada, Y. 2005: Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(4): 163-171
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Sanderson, D.R. 1996: Drug interaction between risperidone and phenytoin resulting in extrapyramidal symptoms Journal of Clinical Psychiatry 57(4): 177
Ahmad, A.R.; Noor, N.A.; Qazi, A.W.; Khan, M.K. 1975: Extrapyramidal reaction induced by thiethylperazine (torecan) Jpma. Journal of the Pakistan Medical Association 25(6): 129-130
Bordeleau, J.M.; Tétreault, L. 1972: Study of extrapyramidal manifestations induced by neuroleptics Revue Canadienne de Biologie 31(Suppl): 247-253
Gross, L.J. 1975: Drug-induced handwriting changes: an empirical review Texas Reports on Biology and Medicine 33(3): 370-390
Brady, J.P. 1998: Drug-induced stuttering: a review of the literature Journal of Clinical Psychopharmacology 18(1): 50-54
Masmoudi, K.; Decocq, G.; Chetaille, E.; Rosa, A.; Mizon, J.P.; Andréjak, M. 1995: Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases Therapie 50(5): 451-454
Sims, J. 1995: The extrapyramidal effects of phenothiazines on patients Nursing Times 91(43): 30-31
Butković-Soldo, S.; Tomić, S.; Stimac, D.; Knezević, L.; Palić, R.; Jurić, S.; Marijanović, K. 2005: Patients review: drug-induced movement disorders Collegium Antropologicum 29(2): 579-582
Gerstenbrand, F.; Poewe, W. 1987: Dopaminergic-peptidergic interactions in extrapyramidal disorders: a review of the clinical evidence Advances in Neurology 45: 67-73
Kane, J.M.; Safferman, A.Z.; Pollack, S.; Johns, C.; Szymanski, S.; Kronig, M.; Lieberman, J.A. 1994: Clozapine, negative symptoms, and extrapyramidal side effects Journal of Clinical Psychiatry 55(Suppl): 74-77
Schnyder, B.; Zanni, M.P.; Pichler, W.J. 1997: Drug-induced hypersensitivity syndrome. A review and presentation of 2 personal cases Schweizerische Medizinische Wochenschrift 127(9): 355-359
Andersson, J.C.; Morel, P.; Poilpre, E.; Baron, J.B. 1977: Statokinesimetric and clinical study of extrapyramidal disorders induced by neuroleptics in a population of mental patients Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 18(Special Issue): 35-43
Bruni, L.; Funaro, G.; Grilli, M.A.; Bernardi, S.; Tozzi, M.C. 1989: Extrapyramidal type collateral effects of the administration of metoclopramide to children La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 11(3): 317-318
Joss, R.A.; Brand, B.C.; Buser, K.S.; Cerny, T. 1990: The symptomatic control of cytostatic drug-induced emesis. a recent history and review European Journal of Cancer 26(Suppl 1): S2-S8
Biedler, J.L.; Spengler, B.A.; Ross, R.A. 1990: Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review Progress in Clinical and Biological Research 354a: 287-312